SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277141
Filing Date
2023-11-14
Accepted
2023-11-14 16:30:48
Documents
13
Period of Report
2023-11-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d281066d8k.htm   iXBRL 8-K 35713
2 EX-3.1 d281066dex31.htm EX-3.1 130558
  Complete submission text file 0001193125-23-277141.txt   332210

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA etnb-20231109.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20231109_lab.xml EX-101.LAB 19483
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20231109_pre.xml EX-101.PRE 12150
7 EXTRACTED XBRL INSTANCE DOCUMENT d281066d8k_htm.xml XML 3671
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 231406995
SIC: 2834 Pharmaceutical Preparations